Back to Rankings

HSTM

HealthStreamA
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
25%
Probability
Target price
$35.00
+22.9% vs current
Most likely
B
Base case
50%
Probability
Target price
$32.00
+12.4% vs current
B-
Bear case
25%
Probability
Target price
$25.50
-10.5% vs current

AI sentiment snapshot

Latest data as of 2026-07-16
Recent news sentiment (30D)
+30.0
Positive
Company
-
Unavailable
Macro
+30.0
Positive
Pulse
-
Unavailable
Sentiment proxy
+55.1
Score

AI commentary

News tone is mildly constructive because Q1 results were described as record-setting and FY2026 guidance was reaffirmed, but headline volume is low. No usable social, options, short-interest, employee, or analyst-revision data was provided; missing market-reaction and revision evidence keeps this a cautious monitoring view.

RankAlpha Sentiment Codex - 2026-07-16
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-10-05eventNext earnings report tests whether Q1 momentum is durableHigh impact

The next quarterly report is the key forward checkpoint for subscription growth, acquisition contribution, margins, and maintenance of FY2026 guidance. Q1 results were accompanied by reaffirmed full-year guidance in the May 4 8-K. [#SEC-8K-2026-05-04]

2026-10-14catalystReaffirmed FY2026 outlook provides near-term supportMedium impact

The May 4 filing confirms that HealthStream announced Q1 results and reaffirmed its FY2026 outlook; this supports sentiment while investors await further operating confirmation, but is largely known and is not a standalone rerating catalyst. [#SEC-8K-2026-05-04]

2027-07-07catalystAcquisition integration and platform cross-sellHigh impact

Virsys12 and MissionCare Collective broadened HealthStream into payer credentialing and career-network workflows. Stored earnings-call context cites $3.4 million of Q1 contribution and continued integration and cross-sell opportunities, but execution remains unproven. [#PR-EARNINGS-2026-05-06]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-07-16 • Updated nightlySource: Internal modelMethodology